The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Open accessAbstract
Endogenous mechanisms that act in the resolution of acute inflammation are essential for host defense and the return to homeostasis. Resolvin D1 (RvD1), biosynthesized during resolution, displays potent and stereoselective anti-inflammatory actions, such as limiting neutrophil infiltration and proresolving actions. Here, we demonstrate that RvD1 actions on human polymorphonuclear leukocytes (PMNs) are pertussis toxin sensitive, decrease actin polymerization, and block LTB 4 -regulated adhesion molecules (β2 integrins). Synthetic [ 3 H]-RvD1 was prepared, which revealed specific RvD1 recognition sites on human leukocytes. Screening systems to identify receptors for RvD1 gave two candidates—ALX, a lipoxin A 4 receptor, and GPR32, an orphan—that were confirmed using a β-arrestin-based ligand receptor system. Nuclear receptors including retinoid X receptor-α and peroxisome proliferator-activated receptor-α, -δ, -γ were not activated by either resolvin E1 or RvD1 at bioactive nanomolar concentrations. RvD1 enhanced macrophage phagocytosis of zymosan and apoptotic PMNs, which increased with overexpression of human ALX and GPR32 and decreased with selective knockdown of these G-protein-coupled receptors. Also, ALX and GPR32 surface expression in human monocytes was up-regulated by zymosan and granulocyte-monocyte–colony-stimulating factor. These results indicate that RvD1 specifically interacts with both ALX and GPR32 on phagocytes and suggest that each plays a role in resolving acute inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,701
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationNeutrophil Mac-1 and MEL-14 Adhesion Proteins Inversely Regulated by Chemotactic Factors
Kishimoto, T. K., Jutila, M. A., Berg, E. L., & Butcher, E. C. (1989) · Science · doi:10.1126/science.2551036 · Cited by 1,090
INFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Serhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Self-citationArita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 922
Self-citationAnnexin A1 and glucocorticoids as effectors of the resolution of inflammation
Perretti, M., & D'Acquisto, F. (2009) · Nature Reviews Immunology · doi:10.1038/nri2470 · Cited by 915
Arita, M., Ohira, T., Sun, Y.-P., Elangovan, S., Chiang, N., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3912 · Cited by 633
Self-citationShimizu, T. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 576
Resolvin D1 and Its Aspirin-triggered 17R Epimer
Sun, Y.-P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., & Serhan, C. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609212200 · Cited by 537
Self-citationThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Self-citationStructural basis for the activation of PPARγ by oxidized fatty acids
Itoh, T., Fairall, L., Amin, K., Inaba, Y., Szanto, A., Balint, B. L., Nagy, L., Yamamoto, K., & Schwabe, J. W. R. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1474 · Cited by 457
Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.
Fiore, S., Maddox, J. F., Perez, H. D., & Serhan, C. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.253 · Cited by 436
Self-citationEndogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus
Serhan, C. N., & Chiang, N. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707489 · Cited by 431
Self-citationMerched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., & Chan, L. (2008) · The FASEB Journal · doi:10.1096/fj.08-112201 · Cited by 414 · cited 1×
“RvD1 limits PMN infiltration at nanogram levels in murine peritonitis and blocks transendothelial migration of human PMNs (8, 12) as well as enhances phagocytosis by human macrophages (MΦ) (13).”
BackgroundSelf-citationImmunomodulation by omega-3 fatty acids
Calder, P. C. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.015 · Cited by 402
Synthetic chemerin-derived peptides suppress inflammation through ChemR23
Cash, J. L., Hart, R., Russ, A., Dixon, J. P. C., Colledge, W. H., Doran, J., Hendrick, A. G., Carlton, M. B. L., & Greaves, D. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071601 · Cited by 372 · cited 1×
“Along these lines, ChemR23 knockout mice are unable to resolve zymosan-induced peritonitis in the presence of C-15, a peptide ligand for this receptor, indicating proresolving signaling by this receptor (27).”
BackgroundResolvin D Series and Protectin D1 Mitigate Acute Kidney Injury
Duffield, J. S., Hong, S., Vaidya, V. S., Lu, Y., Fredman, G., Serhan, C. N., & Bonventre, J. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5902 · Cited by 334
Self-citationChiang, N., Fierro, I. M., Gronert, K., & Serhan, C. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1197 · Cited by 260
Self-citationRapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution
Kasuga, K., Yang, R., Porter, T. F., Agrawal, N., Petasis, N. A., Irimia, D., Toner, M., & Serhan, C. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8677 · Cited by 239
Self-citationhPPARgamma Ligand binding domain in complex with 4-HDHA: 2vv1
Itoh, T., Fairall, L., & Schwabe, J. W. R. (2008) · Worldwide Protein Data Bank · doi:10.2210/pdb2vv1/pdb · Cited by 223
PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis
Barish, G. D., Atkins, A. R., Downes, M., Olson, P., Chong, L.-W., Nelson, M., Zou, Y., Hwang, H., Kang, H., Curtiss, L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711875105 · Cited by 196
Self-citation12(S)-hydroxyheptadeca-5Z, 8E, 10E–trienoic acid is a natural ligand for leukotriene B4 receptor 2
Okuno, T., Iizuka, Y., Okazaki, H., Yokomizo, T., Taguchi, R., & Shimizu, T. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072329 · Cited by 192
Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents
Bürli, R. W., Xu, H., Zou, X., Muller, K. M., Golden, J. E., Frohn, M., Adlam, M. J., Plant, M., Wong, M., McElvain, M. E., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.04.068 · Cited by 125
Perretti, M., Getting, S. J., Solito, E., Murphy, P. M., & Gao, J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64667-6 · Cited by 122
Wilson, S. J., Roche, A. M., Kostetskaia, E., & Smyth, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405002200 · Cited by 108
β Galactosidase Complementation: A Cell-Based Luminescent Assay Platform for Drug Discovery
Olson, K. R., & Eglen, R. M. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.052 · Cited by 80
Haitina, T., Fredriksson, R., Foord, S. M., Schiöth, H. B., & Gloriam, D. E. I. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-24 · Cited by 54
Differential inside-out activation of β2-integrins by leukotriene B4 and fMLP in human neutrophils
Brodin, V. P., Wigren, J., Winberg, M. E., Rasmusson, B. J., Li, J., & Särndahl, E. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.015 · Cited by 40
MADERNA, P., & Godson, C. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.004 · Cited by 38
Cloning Genes Encoding Receptors Related to Chemoattractant Receptors
Marchese, A., Nguyen, T., Malik, P., Xu, S., Cheng, R., Xie, Z., Heng, H. H., George, S. R., Kolakowski, L. F., & O’Dowd, B. F. (1998) · Genomics · doi:10.1006/geno.1998.5297 · Cited by 25
Cited by
Neutrophil Function: From Mechanisms to Disease
Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., & Zychlinsky, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074942 · Cited by 1,708
Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Calder, P. C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04374.x · Cited by 1,347
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Self-citationEmerging targets in neuroinflammation-driven chronic pain
Ji, R.-R., Xu, Z.-Z., & Gao, Y.-J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4334 · Cited by 1,101
Anti-inflammatory Agents: Present and Future
Dinarello, C. A. (2010) · Cell · doi:10.1016/j.cell.2010.02.043 · Cited by 1,095
Metadata
- Authors
- Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.-H., Yang, R., Petasis, N. A., & Serhan, C. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-01-04
- Volume
- 107
- Issue
- 4
- Pages
- 1660-1665
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2030691041
- Cited by
- 730
- References
- 32
- FWCI
- 40.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.